GL1X · GenesisL1 explorer

Research workbench

Crystal structure of PLK1 in complex with a novel 5,6- DIHYDROIMIDAZOLO[1,5-F]PTERIDINE inhibitor

Analyse Crystal structure of PLK1 in complex with a novel 5,6… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5TA8
Type
protein
Length
294 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SERINE/THREONINE-protein kinase PLK1
EC
2.7.11.21
UniProt
P53350
Ligands
79C, ZN
Pockets
5 · best druggability 0.64

Structure

x-ray diffraction · 1 distinct chain · 36% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASERINE/THREONINE-protein kinase PLK1 (EC 2.7.11.21)protein29436% helix, 18% strandP53350

Ligands and binding sites

  • 79C · 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl) amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide · ligand · chains A
  • ZN · Zinc ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12890.640.813579C
21740.550.8020empty
31020.430.7826empty
4550.320.7612empty
5750.320.7415empty

Compared structures

  • 5TA8 · Crystal structure of PLK1 in complex with a novel 5,6-dihydroimidazolo[1,5-f]pteridine… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.